↓ Skip to main content

Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy

Overview of attention for article published in Stem Cell Research & Therapy, December 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy
Published in
Stem Cell Research & Therapy, December 2019
DOI 10.1186/s13287-019-1510-8
Pubmed ID
Authors

Florence van Tienen, Ruby Zelissen, Erika Timmer, Marike van Gisbergen, Patrick Lindsey, Mattia Quattrocelli, Maurilio Sampaolesi, Elvira Mulder-den Hartog, Irenaeus de Coo, Hubert Smeets

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 27%
Researcher 5 19%
Student > Master 2 8%
Professor 1 4%
Other 1 4%
Other 2 8%
Unknown 8 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 19%
Neuroscience 4 15%
Agricultural and Biological Sciences 3 12%
Medicine and Dentistry 3 12%
Immunology and Microbiology 1 4%
Other 2 8%
Unknown 8 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2019.
All research outputs
#10,161,968
of 16,488,620 outputs
Outputs from Stem Cell Research & Therapy
#788
of 1,601 outputs
Outputs of similar age
#211,418
of 381,438 outputs
Outputs of similar age from Stem Cell Research & Therapy
#92
of 218 outputs
Altmetric has tracked 16,488,620 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,601 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 381,438 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.